Published April 2019 | Version v1
Journal article

uPA affects the CRSsNP nasal mucosa epithelium apoptosis by regulating WIF1

  • 1. Department of Otolaryngology, Shanghai General Hospital, Shanghai Jiaotong University, No. 100, Haining Road, Shanghai, 200080 (China)

Description

Chronic rhinosinusitis without nasal polyps (CRSsNP) is the main type of Chronic rhinosinusitis (CRS) and is a common otorhinolaryngologic disease worldwide. However, the mechanisms of CRSsNP remain poorly understood. In this study, C57BL/6J wild-type and urokinase-type plasminogen activator (uPA) gene knockout (uPA-/-) mice were used to construct the CRSsNP model. Primary human nasal epithelial cells (HNEC) were isolated from CRSsNP patient and treated with uPA knockdown/overexpression lentivirus. CCK-8 and Annexin-V/PI staining were used to detected cell proliferation and apoptosis. In vivo, we found that uPA depletion alleviated mucosal inflammation in the CRSsNP mice model. Wnt inhibitory factor 1 (WIF1) was upregulated in the uPA-/- CRSsNP mice model. In vitro, inhibition of uPA increased cell proliferation and decreased cell apoptosis. Mechanistically, uPA depletion upregulated WIF1 and BCL2 expression, and reduced the expression level of BAX in CRSsNP HNEC. In contrast, decreased cell proliferation and increased cell apoptosis were observed after uPA overexpression. Consistently, a reduction in WIF1 and BCL2 expression levels and an increase in the BAX expression level were observed upon uPA ectopic expression. Furthermore, WIF1 overexpression rescued the effects caused by uPA overexpression in vitro. In conclusion, uPA affects the CRSsNP nasal mucosal epithelium cell apoptosis by upregulating WIF1. To our knowledge, this is the first study to explore the role of uPA in CRSsNP to date.

Additional details

Identifiers

DOI
10.1016/j.yexcr.2018.12.024;
PII
S0014482718311881;

Publishing Information

Journal Title
Experimental Cell Research
Journal Volume
377
Journal Issue
1-2
Journal Page Range
p. 75-85
ISSN
0014-4827
CODEN
ECREAL

Optional Information

Copyright
Copyright (c) 2018 Published by Elsevier Inc.